Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
EPZM > SEC Filings for EPZM > Form 8-K on 3-Jul-2013All Recent SEC Filings

Show all filings for EPIZYME, INC.

Form 8-K for EPIZYME, INC.


Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On July 1, 2013, the Board of Directors (the "Board") of Epizyme, Inc. (the "Company") elected Jason P. Rhodes President of the Company in addition to his existing positions as Chief Financial Officer and Treasurer. The election was effective as of July 1, 2013. Prior to the election, Mr. Rhodes, age 43, served as the Company's Executive Vice President, Chief Financial Officer and Treasurer since March 2013 and previously served as the Company's Executive Vice President, Chief Business Officer and Treasurer from March 2010 to March 2013. Prior to joining Epizyme, from July 2007 to March 2010, Mr. Rhodes served as Vice President, Business Development at Alnylam Pharmaceuticals, Inc., a biopharmaceutical company.

In connection with the election of Mr. Rhodes as the Company's President, the Compensation Committee of the Board approved (i) an increase in Mr. Rhodes' base salary, effective as of July 1, 2013, from $355,157 to $372,915, (ii) an increase in Mr. Rhodes' target bonus from 35% to 40% and (iii) the grant of an option to purchase 50,000 shares of the Company's common stock, $0.0001 par value per share, to Mr. Rhodes pursuant to the Company's 2013 Stock Incentive Plan at an exercise price equal to $29.95. The option will vest as to 25% of the shares subject thereto on the first anniversary of the date of grant and monthly and ratably thereafter for a four-year total vesting period.

  Add EPZM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for EPZM - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.